Header Logo

Connection

Ajaypal Singh to Humans

Back to Details
This is a "connection" page, showing publications Ajaypal Singh has written about Humans.
Ajaypal Singh
Connection Strength
2.907
Humans
  1. Introduction: A Multi-Pronged Approach to CKD Associated With Type 2 Diabetes. Semin Nephrol. 2023 05; 43(3):151444.
    View in: PubMed
    Score: 0.052
  2. Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials. Nephrol Dial Transplant. 2023 07 31; 38(8):1890-1897.
    View in: PubMed
    Score: 0.051
  3. Does Prescription Length of Buprenorphine Influence Treatment Outcomes in Opioid Use Disorder? A Retrospective Cohort Study from North India. Subst Use Misuse. 2023; 58(12):1620-1624.
    View in: PubMed
    Score: 0.050
  4. Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023 Jun 15; 388(24):2301.
    View in: PubMed
    Score: 0.050
  5. Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D). Am J Nephrol. 2023; 54(1-2):1-13.
    View in: PubMed
    Score: 0.049
  6. The ASCEND-ND trial: study design and participant characteristics. Nephrol Dial Transplant. 2022 10 19; 37(11):2157-2170.
    View in: PubMed
    Score: 0.048
  7. Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial. JAMA Intern Med. 2022 06 01; 182(6):592-602.
    View in: PubMed
    Score: 0.047
  8. Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial. Nephrol Dial Transplant. 2022 04 25; 37(5):960-972.
    View in: PubMed
    Score: 0.046
  9. Debate: Are HIF Stabilizers a Viable Alternative to ESAs in the Management of Anemia in CKD? PRO. Am J Nephrol. 2022; 53(5):361-365.
    View in: PubMed
    Score: 0.046
  10. Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience. Kidney360. 2022 04 28; 3(4):728-733.
    View in: PubMed
    Score: 0.046
  11. Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. N Engl J Med. 2021 12 16; 385(25):2325-2335.
    View in: PubMed
    Score: 0.045
  12. Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis. N Engl J Med. 2021 12 16; 385(25):2313-2324.
    View in: PubMed
    Score: 0.045
  13. Occupational risk factors for chronic kidney disease in Andhra Pradesh: 'Uddanam Nephropathy'. Ren Fail. 2020 Nov; 42(1):1032-1041.
    View in: PubMed
    Score: 0.042
  14. Multiparametric Cardiac Magnetic Resonance for Chronic Kidney Disease: Mapping the Footprints of a "Silent Killer"? JACC Cardiovasc Imaging. 2020 11; 13(11):2368-2370.
    View in: PubMed
    Score: 0.042
  15. Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019 11; 28(6):600-606.
    View in: PubMed
    Score: 0.039
  16. Necrotizing fasciitis of the lower extremity: imaging pearls and pitfalls. Br J Radiol. 2018 Jul; 91(1088):20180093.
    View in: PubMed
    Score: 0.035
  17. Recreational use of marijuana: Current experience and information for nephrologists. Nephrol News Issues. 2017 Apr; 31(4):32-33.
    View in: PubMed
    Score: 0.033
  18. A review of penetrating brain trauma: epidemiology, pathophysiology, imaging assessment, complications, and treatment. Emerg Radiol. 2017 Jun; 24(3):301-309.
    View in: PubMed
    Score: 0.032
  19. The International Society of Nephrology (ISN) and the American Nephrologists of Indian Origin (ANIO) Online Clinical Nephropathology Certificate (CNC) program. Kidney Int. 2016 May; 89(5):966-968.
    View in: PubMed
    Score: 0.031
  20. Blast Injuries: From Improvised Explosive Device Blasts to the Boston Marathon Bombing. Radiographics. 2016 Jan-Feb; 36(1):295-307.
    View in: PubMed
    Score: 0.030
  21. Imaging of abdominal and pelvic injuries from the Boston Marathon bombing. Emerg Radiol. 2016 Feb; 23(1):35-39.
    View in: PubMed
    Score: 0.029
  22. The Role of Endoscopy in the Diagnosis and Management of Cholangiocarcinoma. J Clin Gastroenterol. 2015 Oct; 49(9):725-37.
    View in: PubMed
    Score: 0.029
  23. Head and neck injuries from the Boston Marathon bombing at four hospitals. Emerg Radiol. 2015 Oct; 22(5):527-32.
    View in: PubMed
    Score: 0.029
  24. Adverse events associated with percutaneous enteral access. Gastrointest Endosc Clin N Am. 2015 Jan; 25(1):71-82.
    View in: PubMed
    Score: 0.028
  25. Predictors of renal replacement therapy and mortality in children with chronic kidney disease. Saudi Med J. 2015 Jan; 36(1):32-9.
    View in: PubMed
    Score: 0.028
  26. Radiologic features of injuries from the Boston Marathon bombing at three hospitals. AJR Am J Roentgenol. 2014 Aug; 203(2):235-9.
    View in: PubMed
    Score: 0.027
  27. Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol. 2014 Mar 06; 15:42.
    View in: PubMed
    Score: 0.026
  28. Sudden cardiac arrest in ESRD patients. Clin Nephrol. 2014 Feb; 81(2):121-31.
    View in: PubMed
    Score: 0.026
  29. Consanguinity in Saudi Arabia: a unique opportunity for pediatric kidney research. Am J Kidney Dis. 2014 Feb; 63(2):304-10.
    View in: PubMed
    Score: 0.026
  30. Prevalence of vitamin D deficiency in Saudi adults. Saudi Med J. 2013 Aug; 34(8):814-8.
    View in: PubMed
    Score: 0.025
  31. How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The itsy bitsy anemia problem. Semin Dial. 2013 Sep-Oct; 26(5):531-4.
    View in: PubMed
    Score: 0.025
  32. Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol. 2013 May 28; 14:114.
    View in: PubMed
    Score: 0.025
  33. Con: Randomized controlled trials (RCT) have failed in the study of dialysis methods. Nephrol Dial Transplant. 2013 Apr; 28(4):826-32; discussion 832.
    View in: PubMed
    Score: 0.025
  34. Pro: The value of randomized controlled studies in dialysis methods. Nephrol Dial Transplant. 2013 Apr; 28(4):834-5; discussion 835-6.
    View in: PubMed
    Score: 0.025
  35. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens. 2013 Mar; 22(2):198-203.
    View in: PubMed
    Score: 0.025
  36. Chronic kidney disease in the Arab world: a call for action. Nephron Clin Pract. 2012; 121(3-4):c120-3.
    View in: PubMed
    Score: 0.024
  37. Anaemia: Does the KDIGO guideline move the needle in CKD anaemia? Nat Rev Nephrol. 2012 Nov; 8(11):616-8.
    View in: PubMed
    Score: 0.024
  38. Modulation of platelet activation in chronic kidney disease patients on erythropoiesis-stimulating agents. Clin Appl Thromb Hemost. 2012 Sep; 18(5):453-61.
    View in: PubMed
    Score: 0.023
  39. Image-guided percutaneous splenic interventions. Radiographics. 2012 Mar-Apr; 32(2):523-34.
    View in: PubMed
    Score: 0.023
  40. Is there a deleterious effect of erythropoietin in end-stage renal disease? Kidney Int. 2011 Sep; 80(6):569-71.
    View in: PubMed
    Score: 0.022
  41. ASN clinicopathologic conference. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2722-8.
    View in: PubMed
    Score: 0.022
  42. Imaging of preoperative liver transplantation in adults: what radiologists should know. Radiographics. 2011 Jul-Aug; 31(4):1017-30.
    View in: PubMed
    Score: 0.022
  43. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study. Saudi J Kidney Dis Transpl. 2010 Nov; 21(6):1066-72.
    View in: PubMed
    Score: 0.021
  44. What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level? Curr Opin Nephrol Hypertens. 2010 Sep; 19(5):420-4.
    View in: PubMed
    Score: 0.021
  45. Message to the FDA on ESAs: REMS is not enough, more studies are needed. Clin J Am Soc Nephrol. 2010 Aug; 5(8):1355-8.
    View in: PubMed
    Score: 0.021
  46. Diabetes, anemia and CKD: Why TREAT? Curr Diab Rep. 2010 Aug; 10(4):291-6.
    View in: PubMed
    Score: 0.021
  47. Even in nephrology, gurudakshina is important. Kidney Int. 2010 Jul; 78(1):3-5.
    View in: PubMed
    Score: 0.020
  48. The etiology of anemia in heart failure. Preface. Heart Fail Clin. 2010 Jul; 6(3):xvii-xviii.
    View in: PubMed
    Score: 0.020
  49. Therapy with erythropoiesis-stimulating agents and renal and nonrenal outcomes. Heart Fail Clin. 2010 Jul; 6(3):323-32.
    View in: PubMed
    Score: 0.020
  50. Anemia in chronic kidney disease: new advances. Heart Fail Clin. 2010 Jul; 6(3):347-57.
    View in: PubMed
    Score: 0.020
  51. Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed? Am J Nephrol. 2010; 31(6):552-6; discussion 563-4.
    View in: PubMed
    Score: 0.020
  52. ESAs in dialysis patients: are you a hedgehog or a fox? J Am Soc Nephrol. 2010 Apr; 21(4):543-6.
    View in: PubMed
    Score: 0.020
  53. The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol. 2010 Apr; 5(4):553-6.
    View in: PubMed
    Score: 0.020
  54. Postoperative imaging in liver transplantation: what radiologists should know. Radiographics. 2010 Mar; 30(2):339-51.
    View in: PubMed
    Score: 0.020
  55. Should we keep hemoglobin levels as a viable outcome measure? Nephrol News Issues. 2010 Mar; 24(3):15-6, 18.
    View in: PubMed
    Score: 0.020
  56. Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol. 2010 Jan; 21(1):2-6.
    View in: PubMed
    Score: 0.020
  57. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis. 2010 Mar; 55(3):590-8.
    View in: PubMed
    Score: 0.020
  58. A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. Kidney Int. 2010 Feb; 77(3):239-46.
    View in: PubMed
    Score: 0.020
  59. Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro. J Am Soc Nephrol. 2009 Jul; 20(7):1436-41.
    View in: PubMed
    Score: 0.019
  60. Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis. 2009 May; 53(5):751-9.
    View in: PubMed
    Score: 0.019
  61. Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. Semin Nephrol. 2009 Mar; 29(2):105-12.
    View in: PubMed
    Score: 0.019
  62. Role of vitamin D in chronic kidney disease. Semin Nephrol. 2009 Mar; 29(2):113-21.
    View in: PubMed
    Score: 0.019
  63. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now? Am J Kidney Dis. 2008 Dec; 52(6 Suppl):S5-13.
    View in: PubMed
    Score: 0.018
  64. Core biopsy with curved needle technique. AJR Am J Roentgenol. 2008 Dec; 191(6):1745-50.
    View in: PubMed
    Score: 0.018
  65. Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. Nephron Clin Pract. 2008; 110(4):c244-50.
    View in: PubMed
    Score: 0.018
  66. Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation. Kidney Int. 2008 Dec; 74(12):1588-95.
    View in: PubMed
    Score: 0.018
  67. Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1246-52.
    View in: PubMed
    Score: 0.018
  68. Emergency MRI of acute pelvic pain: MR protocol with no oral contrast. Emerg Radiol. 2009 Mar; 16(2):133-41.
    View in: PubMed
    Score: 0.018
  69. Hemoglobin target in chronic kidney disease: a pediatric perspective. Pediatr Nephrol. 2009 Mar; 24(3):431-4.
    View in: PubMed
    Score: 0.018
  70. Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int. 2008 Sep; 74(6):791-8.
    View in: PubMed
    Score: 0.018
  71. Neoplastic iliopsoas masses in oncology patients: CT findings. Abdom Imaging. 2008 Jul-Aug; 33(4):493-7.
    View in: PubMed
    Score: 0.018
  72. Acute phosphate nephropathy. Kidney Int. 2009 May; 75(9):987-91.
    View in: PubMed
    Score: 0.018
  73. Iron deficiency in non-dialysis chronic kidney disease. Kidney Int. 2009 Apr; 75(7):752-4.
    View in: PubMed
    Score: 0.018
  74. De novo multifocal renal cell carcinoma in the renal allograft. Kidney Int. 2009 Jan; 75(1):111-4.
    View in: PubMed
    Score: 0.018
  75. Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. Kidney Int. 2008 Sep; 74(6):782-90.
    View in: PubMed
    Score: 0.018
  76. Pure red cell aplasia due to follow-on epoetin. Kidney Int. 2008 Dec; 74(12):1617-22.
    View in: PubMed
    Score: 0.018
  77. Acute coronary syndrome in ESRD patients. Kidney Int. 2009 Mar; 75(5):558-62.
    View in: PubMed
    Score: 0.018
  78. Managing anemia in dialysis patients: hemoglobin cycling and overshoot. Kidney Int. 2008 Sep; 74(5):679-83.
    View in: PubMed
    Score: 0.017
  79. Dropped appendicolith: CT findings and implications for management. AJR Am J Roentgenol. 2008 Mar; 190(3):707-11.
    View in: PubMed
    Score: 0.017
  80. Prevention of intravenous contrast-induced nephropathy in hospital inpatients. Crit Pathw Cardiol. 2008 Mar; 7(1):1-4.
    View in: PubMed
    Score: 0.017
  81. The optimal hemoglobin in dialysis patients- a critical review. Semin Dial. 2008 Jan-Feb; 21(1):1-6.
    View in: PubMed
    Score: 0.017
  82. Anemia of chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jan; 3(1):3-6.
    View in: PubMed
    Score: 0.017
  83. The nephrology quiz and questionnaire: 2006. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1375-88.
    View in: PubMed
    Score: 0.017
  84. Does correction of anemia slow the progression of chronic kidney disease? Nat Clin Pract Nephrol. 2007 Dec; 3(12):638-9.
    View in: PubMed
    Score: 0.017
  85. Is it time to reconsider subcutaneous administration of epoetin? Nephrol News Issues. 2007 Oct; 21(11):57, 59, 63-4 passim.
    View in: PubMed
    Score: 0.017
  86. Anemia of chronic kidney disease: CHOIR and the FDA. Nat Clin Pract Nephrol. 2007 Aug; 3(8):406-7.
    View in: PubMed
    Score: 0.017
  87. The FDA black box for EPO: what should nephrologists do? Nephrol News Issues. 2007 May; 21(6):55-6, 58-9.
    View in: PubMed
    Score: 0.016
  88. Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease. Endocr Pract. 2007 May-Jun; 13(3):251-9.
    View in: PubMed
    Score: 0.016
  89. Anaemia of CKD--the CHOIR study revisited. Nephrol Dial Transplant. 2007 Jul; 22(7):1806-10.
    View in: PubMed
    Score: 0.016
  90. Imaging-guided catheter drainage of abdominal collections with fistulous pancreaticobiliary communication. AJR Am J Roentgenol. 2006 Dec; 187(6):1591-6.
    View in: PubMed
    Score: 0.016
  91. The target hemoglobin in patients with chronic kidney disease. Nephrol News Issues. 2006 Dec; 20(13):29-30.
    View in: PubMed
    Score: 0.016
  92. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006 Nov 16; 355(20):2085-98.
    View in: PubMed
    Score: 0.016
  93. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation. 2006 Sep 15; 82(5):612-8.
    View in: PubMed
    Score: 0.016
  94. Acute epiploic appendagitis and its mimics. Radiographics. 2005 Nov-Dec; 25(6):1521-34.
    View in: PubMed
    Score: 0.015
  95. Imaging of penile neoplasms. Radiographics. 2005 Nov-Dec; 25(6):1629-38.
    View in: PubMed
    Score: 0.015
  96. Acute epiploic appendagitis in hernia sac: CT appearance. Emerg Radiol. 2005 Jun; 11(4):226-7.
    View in: PubMed
    Score: 0.014
  97. Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease. Med Clin North Am. 2005 May; 89(3):549-61.
    View in: PubMed
    Score: 0.014
  98. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease. Nephrol Nurs J. 2005 Mar-Apr; 32(2):199-206; quiz 207-8.
    View in: PubMed
    Score: 0.014
  99. The role of kidney biopsy in the management of lupus nephritis. Curr Opin Nephrol Hypertens. 2005 Jan; 14(1):1-8.
    View in: PubMed
    Score: 0.014
  100. New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis. 2004 Dec; 44(6):1050-9.
    View in: PubMed
    Score: 0.014
  101. CT appearance of acute appendagitis. AJR Am J Roentgenol. 2004 Nov; 183(5):1303-7.
    View in: PubMed
    Score: 0.014
  102. Pancreatoduodenectomy: imaging and image-guided interventional treatment. Semin Ultrasound CT MR. 2004 Jun; 25(3):252-60.
    View in: PubMed
    Score: 0.013
  103. Cholecystocolonic fistula: serial CT imaging features. Emerg Radiol. 2004 Jul; 10(6):301-2.
    View in: PubMed
    Score: 0.013
  104. Strategies for preservation of ovarian and testicular function after immunosuppression. Am J Kidney Dis. 2004 May; 43(5):772-81.
    View in: PubMed
    Score: 0.013
  105. Omental infarct: an unusual CT appearance after superior mesenteric artery occlusion. Emerg Radiol. 2004 Apr; 10(5):276-8.
    View in: PubMed
    Score: 0.013
  106. Imaging of inflammatory bowel disease: CT and MR. Dig Dis. 2004; 22(1):56-62.
    View in: PubMed
    Score: 0.013
  107. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2003. A 68-year-old woman with impaired renal function. N Engl J Med. 2003 Nov 20; 349(21):2055-63.
    View in: PubMed
    Score: 0.013
  108. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol. 2003 Oct; 14(10):2573-80.
    View in: PubMed
    Score: 0.013
  109. Bouveret's syndrome: appearance on CT and upper gastrointestinal radiography before and after stone obturation. AJR Am J Roentgenol. 2003 Sep; 181(3):828-30.
    View in: PubMed
    Score: 0.013
  110. The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease. Kidney Int. 2023 06; 103(6):1180-1192.
    View in: PubMed
    Score: 0.012
  111. Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply. N Engl J Med. 2022 12 29; 387(26):2482-2485.
    View in: PubMed
    Score: 0.012
  112. GIE Editorial Board Top 10: advances in GI endoscopy in 2021. Gastrointest Endosc. 2022 12; 96(6):1062-1070.
    View in: PubMed
    Score: 0.012
  113. Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial. Clin J Am Soc Nephrol. 2022 09; 17(9):1325-1336.
    View in: PubMed
    Score: 0.012
  114. Immunopathogenesis of lupus and lupus nephritis: recent insights. Curr Opin Nephrol Hypertens. 2002 May; 11(3):273-7.
    View in: PubMed
    Score: 0.012
  115. Innovative methods of improving mental health literacy in a rural setting. Asian J Psychiatr. 2020 Aug; 52:102037.
    View in: PubMed
    Score: 0.010
  116. Renal pathology practice globally: identifying needs and meeting the challenge. Kidney Int. 2019 08; 96(2):258-261.
    View in: PubMed
    Score: 0.010
  117. Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia. N Engl J Med. 2019 Jul 18; 381(3):275-283.
    View in: PubMed
    Score: 0.010
  118. Accuracy and timeliness of an abbreviated emergency department MRCP protocol for choledocholithiasis. Emerg Radiol. 2019 Aug; 26(4):427-432.
    View in: PubMed
    Score: 0.009
  119. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2019 05; 21(5):1199-1208.
    View in: PubMed
    Score: 0.009
  120. Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2019 03; 73(3):309-315.
    View in: PubMed
    Score: 0.009
  121. The Prevalence, Clinical Spectrum and the Long Term Outcome of ST-segment Elevation Myocardial Infarction in Young - A Prospective Observational Study. Cardiovasc Revasc Med. 2019 05; 20(5):387-391.
    View in: PubMed
    Score: 0.009
  122. The added value of cross-sectional imaging in the detection of additional radiographically occult fractures in the setting of a Chopart fracture. Emerg Radiol. 2018 Oct; 25(5):513-520.
    View in: PubMed
    Score: 0.009
  123. Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial. Am J Nephrol. 2017; 46(6):488-497.
    View in: PubMed
    Score: 0.009
  124. BP in Dialysis: Results of a Pilot Study. J Am Soc Nephrol. 2018 01; 29(1):307-316.
    View in: PubMed
    Score: 0.009
  125. A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease. Am J Nephrol. 2017; 46(5):364-370.
    View in: PubMed
    Score: 0.008
  126. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type?2 Diabetic Patients With CKD. Am J Kidney Dis. 2017 Oct; 70(4):522-531.
    View in: PubMed
    Score: 0.008
  127. C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2016 Dec; 68(6):873-881.
    View in: PubMed
    Score: 0.008
  128. Prevalence of Hyperparathyroidism, Mineral and Bone Disorders in Children with Advanced Chronic Kidney Disease. Indian J Pediatr. 2016 May; 83(5):420-5.
    View in: PubMed
    Score: 0.008
  129. Pretransplantation Imaging Workup of the Liver Donor and Recipient. Radiol Clin North Am. 2016 Mar; 54(2):185-97.
    View in: PubMed
    Score: 0.007
  130. Ferric pyrophosphate citrate (Triferic?) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients. Nephrol Dial Transplant. 2015 Dec; 30(12):2019-26.
    View in: PubMed
    Score: 0.007
  131. Cause of Death in Patients With Diabetic CKD Enrolled in the?Trial to Reduce Cardiovascular Events With Aranesp Therapy?(TREAT). Am J Kidney Dis. 2015 Sep; 66(3):429-40.
    View in: PubMed
    Score: 0.007
  132. Outcome of acute kidney injury in pediatric patients admitted to the intensive care unit. Clin Nephrol. 2014 Dec; 82(6):379-86.
    View in: PubMed
    Score: 0.007
  133. Terrorist bombings: foreign bodies from the Boston Marathon bombing. Semin Ultrasound CT MR. 2015 Feb; 36(1):68-72.
    View in: PubMed
    Score: 0.007
  134. Cognitive function and all-cause mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2015 Feb; 65(2):303-11.
    View in: PubMed
    Score: 0.007
  135. The case | Renal tubular acidosis and eye findings. Kidney Int. 2014 Jul; 86(1):217-8.
    View in: PubMed
    Score: 0.007
  136. Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease. Am J Nephrol. 2013; 37(6):549-58.
    View in: PubMed
    Score: 0.006
  137. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013 Jan 29; 80(5):471-80.
    View in: PubMed
    Score: 0.006
  138. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis. 2013 Feb; 61(2):238-46.
    View in: PubMed
    Score: 0.006
  139. Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. Am J Kidney Dis. 2012 Sep; 60(3):390-401.
    View in: PubMed
    Score: 0.006
  140. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation. 2011 Dec 20; 124(25):2903-8.
    View in: PubMed
    Score: 0.006
  141. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med. 2010 Sep 16; 363(12):1146-55.
    View in: PubMed
    Score: 0.005
  142. Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy. Nephron Clin Pract. 2010; 115(2):c100-6.
    View in: PubMed
    Score: 0.005
  143. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010 May; 25(5):1567-75.
    View in: PubMed
    Score: 0.005
  144. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009 Nov 19; 361(21):2019-32.
    View in: PubMed
    Score: 0.005
  145. Disclosure of the HIV infection status in children. Indian J Pediatr. 2009 Aug; 76(8):805-8.
    View in: PubMed
    Score: 0.005
  146. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Am J Kidney Dis. 2009 Sep; 54(3):498-510.
    View in: PubMed
    Score: 0.005
  147. Posttransplant anemia: the role of sirolimus. Kidney Int. 2009 Aug; 76(4):376-82.
    View in: PubMed
    Score: 0.005
  148. Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2009 Jul; 54(1):59-69.
    View in: PubMed
    Score: 0.005
  149. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis. 2009 Jan; 53(1):26-32.
    View in: PubMed
    Score: 0.005
  150. Fournier gangrene: role of imaging. Radiographics. 2008 Mar-Apr; 28(2):519-28.
    View in: PubMed
    Score: 0.004
  151. Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol. 2008 Feb; 19(2):372-9.
    View in: PubMed
    Score: 0.004
  152. Reducing versus discontinuing erythropoietin at high hemoglobin levels. J Am Soc Nephrol. 2007 Dec; 18(12):3184-91.
    View in: PubMed
    Score: 0.004
  153. Tc-99m ciprofloxacin scans for detection of tubercular bone infection. Clin Nucl Med. 2007 May; 32(5):367-70.
    View in: PubMed
    Score: 0.004
  154. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol. 2007 Mar; 18(3):975-84.
    View in: PubMed
    Score: 0.004
  155. Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure. Clin J Am Soc Nephrol. 2006 May; 1(3):455-61.
    View in: PubMed
    Score: 0.004
  156. Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J. 2005 Mar; 149(3):408-13.
    View in: PubMed
    Score: 0.004
  157. Uncertainty in the treatment of anemia in chronic kidney disease. Rev Cardiovasc Med. 2005; 6 Suppl 3:S35-41.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.